menu
    • menu

    Company profile for Stevanato Group

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 1949, the Stevanato Group is the world’s largest, privately owned designer and producer of glass parenteral packaging for the pharmaceutical industry. From the outset, Stevanato has been self-sufficient in developing the necessary technology and machinery required to ensure the highest standards of quality and innovation throughout the production process. We are fully committed to be the preferred partner in the ...
    Founded in 1949, the Stevanato Group is the world’s largest, privately owned designer and producer of glass parenteral packaging for the pharmaceutical industry. From the outset, Stevanato has been self-sufficient in developing the necessary technology and machinery required to ensure the highest standards of quality and innovation throughout the production process. We are fully committed to be the preferred partner in the research and delivery of innovative components and systems to support our customers' needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Stevanato GroupItaly Flag
    Country
    Country
    Italy
    Address
    Address
    via Molinella 17Piombino Desse, PD 35018
    Telephone
    Telephone
    +39 04 99 31 81 12
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.stevanatogroup.com/en/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/stevanato-group
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Stevanato Group Reports 7% Revenue Growth in FY 2025
    Stevanato Group Reports 7% Revenue Growth in FY 2025

    04 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-04/stevanato-group-delivers-7-revenue-growth-9-at-constant-currency-for-fiscal-year-2025-including

    PHARMIWEB
    04 Mar 2026
    Share Share
    Stevanato Group To Release Q4 & FY 2025 Financial Results
    Stevanato Group To Release Q4 & FY 2025 Financial Results

    19 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-19/stevanato-group-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-4-2026

    PHARMIWEB
    19 Feb 2026
    Share Share
    Datwyler, LTS Device, & Stevanato Collab to Self-Delivery Options
    Datwyler, LTS Device, & Stevanato Collab to Self-Delivery Options

    16 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/datwyler-lts-device-technologies-and-stevanato-group-collaborate-to-expand-self-delivery-options-for-large-volume-drugs-302662857.html

    PR NEWSWIRE
    16 Jan 2026
    Share Share
    Stevanato Group Generates €303.2M Revenue In Q3 2025
    Stevanato Group Generates €303.2M Revenue In Q3 2025

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106498195/en/Stevanato-Group-Reports-Revenue-of-%E2%82%AC303.2-Million-for-the-Third-Quarter-of-2025

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Stevanato Group to Participate in Upcoming Investor Conferences
    Stevanato Group to Participate in Upcoming Investor Conferences

    31 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031945746/en/Stevanato-Group-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    31 Oct 2025
    Share Share
    Stevanato Group To Release Q3 2025 Financial Results On Nov 6
    Stevanato Group To Release Q3 2025 Financial Results On Nov 6

    22 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251022261467/en/Stevanato-Group-to-Report-Third-Quarter-2025-Financial-Results-on-November-6-2025

    BUSINESSWIRE
    22 Oct 2025
    Share Share

    Services

    Upload your portfolio for free, ask us

    Packaging

    Click here to discover the service providers for Packaging

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search